Dingfelder, J.; Taubmann, J.; von Heydebrand, F.; Aigner, M.; Bergmann, C.; Knitza, J.; Park, S.; Cheng, J.K.; Van Blarcom, T.; Schett, G.;
et al. Exploring CAR T-Cell Dynamics: Balancing Potent Cytotoxicity and Controlled Inflammation in CAR T-Cells Derived from Systemic Sclerosis and Myositis Patients. Int. J. Mol. Sci. 2025, 26, 467.
https://doi.org/10.3390/ijms26020467
AMA Style
Dingfelder J, Taubmann J, von Heydebrand F, Aigner M, Bergmann C, Knitza J, Park S, Cheng JK, Van Blarcom T, Schett G,
et al. Exploring CAR T-Cell Dynamics: Balancing Potent Cytotoxicity and Controlled Inflammation in CAR T-Cells Derived from Systemic Sclerosis and Myositis Patients. International Journal of Molecular Sciences. 2025; 26(2):467.
https://doi.org/10.3390/ijms26020467
Chicago/Turabian Style
Dingfelder, Janin, Jule Taubmann, Franziska von Heydebrand, Michael Aigner, Christina Bergmann, Johannes Knitza, Soo Park, Joseph K. Cheng, Thomas Van Blarcom, Georg Schett,
and et al. 2025. "Exploring CAR T-Cell Dynamics: Balancing Potent Cytotoxicity and Controlled Inflammation in CAR T-Cells Derived from Systemic Sclerosis and Myositis Patients" International Journal of Molecular Sciences 26, no. 2: 467.
https://doi.org/10.3390/ijms26020467
APA Style
Dingfelder, J., Taubmann, J., von Heydebrand, F., Aigner, M., Bergmann, C., Knitza, J., Park, S., Cheng, J. K., Van Blarcom, T., Schett, G., Mackensen, A., & Lutzny-Geier, G.
(2025). Exploring CAR T-Cell Dynamics: Balancing Potent Cytotoxicity and Controlled Inflammation in CAR T-Cells Derived from Systemic Sclerosis and Myositis Patients. International Journal of Molecular Sciences, 26(2), 467.
https://doi.org/10.3390/ijms26020467
